Back to Search
Start Over
Residual Risk for Transfusion-Transmitted HIV and Cost-Benefit for HIV Nucleic Acid Amplification Technology (NAT) in Brazil.
- Source :
-
Transfusion . Sep2002 Supplement 1, Vol. 42, p3S-3S. 1/4p. - Publication Year :
- 2002
-
Abstract
- Discusses the abstract of the research paper 'Residual Risk for Transfusion-Transmitted HIV and Cost-Benefit for HIV Nucleic Acid Amplification Technology in Brazil,' by L. Amorim, C. Silvia, et al, to be presented at the American Association of Blood Banks' 55th Annual Meeting on October 26-29, 2002.
- Subjects :
- *NUCLEIC acids
*HIV infection transmission
*BLOOD transfusion
Subjects
Details
- Language :
- English
- ISSN :
- 00411132
- Volume :
- 42
- Database :
- Academic Search Index
- Journal :
- Transfusion
- Publication Type :
- Academic Journal
- Accession number :
- 10796368